Chronic sleep disturbance could trigger onset of Alzheimer's

March 18, 2014, Temple University

People who experience chronic sleep disturbance—either through their work, insomnia or other reasons—could face an earlier onset of dementia and Alzheimer's, according to a new pre-clinical study by researchers at Temple University.

"The big biological question that we tried to address in this study is whether sleep disturbance is a risk factor to develop Alzheimer's or is it something that manifests with the disease," said Domenico Praticò, professor of pharmacology and microbiology/immunology in Temple's School of Medicine, who led the study.

Initially, the researchers looked at longitudinal studies which indicated that people who reported chronic sleep disturbances often developed Alzheimer's disease.

For the study, they used a transgenic Alzheimer's mouse model that begins developing memory and learning impairment at about one year—the equivalent of a human that is mid-50-60 years in age—and at 14-15 months have the typical human brain pathology of Alzheimer's, including and tau protein tangles, the two major brain pathological/lesion signatures for the disease.

The eight week study began when the mice were approximately six months old, or the equivalent of an adult human in their 40s. One group of mice was kept on a schedule of 12 hours of light and 12 hours of darkness, while a second group was subjected to 20 hours of light and only four hours of darkness, greatly reducing their amount of sleep.

"At the end of the eight weeks, we didn't initially observe anything that was obviously different between the two groups," said Praticὸ, who is also a member of Temple's Center for Translational Medicine. "However, when we tested the mice for memory, the group which had the reduced sleep demonstrated significant impairment in their working and retention memory, as well as their learning ability."

The researchers then examined the mice's brains to look at the different aspects of the Alzheimer's pathology—mainly the amyloid plaques and tau protein tangles.

"Surprisingly, we didn't see any difference between the two groups in the amyloid plaques," noted Praticὸ. "However, we did observe that the sleep disturbance group had a significant increase in the amount of that became phosphorylated and formed the tangles inside the brain's neuronal cells."

Tau protein acts as an important component for neuronal cell health, but elevated levels of phosphorylated tau can disrupt the cells' synaptic connection or ability to transport a nutrient/chemical or transmit an electrical signal from one cell to another, said Praticò.

"Because of the tau's abnormal phosphorylation, the sleep deprived mice had a huge disruption of this synaptic connection," he said. "This disruption will eventually impair the brain's ability for learning, forming new memory and other cognitive functions, and contributes to Alzheimer's disease."

Praticὸ said that since the sleep deprived mice developed the Alzheimer's brain pathology earlier than the mice who were not deprived, sleep disturbance acts as a trigger that accelerates the pathological process of tau becoming phosphorylated and irreversibly damaging the synaptic connection.

"We can conclude from this study that chronic sleep disturbance is an environmental risk factor for Alzheimer's disease," he said. "But the good news is that can be easily treated, which would hopefully reduce the Alzheimer's risk."

Explore further: Stress hormone could trigger mechanism for the onset of Alzheimer's

More information: The researchers published their findings, "Sleep deprivation impairs memory, tau metabolism and synaptic integrity of a mouse model of Alzheimer's disease with plaques and tangles," in the journal Neurobiology of Aging.

Related Stories

Stress hormone could trigger mechanism for the onset of Alzheimer's

June 21, 2013
(Medical Xpress)—A chemical hormone released in the body as a reaction to stress could be a key trigger of the mechanism for the late onset of Alzheimer's disease, according to a study by researchers at Temple University.

New Alzheimer's research suggests possible cause: The interaction of proteins in the brain

June 19, 2013
For years, Alzheimer's researchers have focused on two proteins that accumulate in the brains of people with Alzheimer's and may contribute to the disease: plaques made up of the protein amyloid-beta, and tangles of another ...

Fluorescent compounds allow clinicians to visualize Alzheimer's disease as it progresses

September 18, 2013
What if doctors could visualize all of the processes that take place in the brain during the development and progression of Alzheimer's disease? Such a window would provide a powerful aid for diagnosing the condition, monitoring ...

Brain cell activity regulates Alzheimer's protein

February 26, 2014
Increased brain cell activity boosts brain fluid levels of a protein linked to Alzheimer's disease, according to new research from scientists at Washington University School of Medicine in St. Louis.

Shorter sleep duration and poorer sleep quality linked to Alzheimer's disease biomarker

October 21, 2013
Poor sleep quality may impact Alzheimer's disease onset and progression. This is according to a new study led by researchers at the Johns Hopkins Bloomberg School of Public Health who examined the association between sleep ...

How age opens the gates for Alzheimer's

March 18, 2014
With advancing age, highly-evolved brain circuits become susceptible to molecular changes that can lead to neurofibrillary tangles—a hallmark of Alzheimer's Disease, Yale researchers report the week of March 17 in the Proceedings ...

Recommended for you

Anxiety: An early indicator of Alzheimer's disease?

January 12, 2018
A new study suggests an association between elevated amyloid beta levels and the worsening of anxiety symptoms. The findings support the hypothesis that neuropsychiatric symptoms could represent the early manifestation of ...

One of the most promising drugs for Alzheimer's disease fails in clinical trials

January 11, 2018
To the roughly 400 clinical trials that have tested some experimental treatment for Alzheimer's disease and come up short, we can now add three more.

Different disease types associated with distinct amyloid-beta prion strains found in Alzheimer's patients

January 9, 2018
An international team of researchers has found different disease type associations with distinct amyloid-beta prion strains in the brains of dead Alzheimer's patients. In their paper published in Proceedings of the National ...

Advances in brain imaging settle debate over spread of key protein in Alzheimer's

January 5, 2018
Recent advances in brain imaging have enabled scientists to show for the first time that a key protein which causes nerve cell death spreads throughout the brain in Alzheimer's disease - and hence that blocking its spread ...

Molecular mechanism behind HIV-associated dementia revealed

January 5, 2018
For the first time, scientists have identified and inhibited a molecular process that can lead to neurodegeneration in patients with HIV, according to a Northwestern Medicine study published in Nature Communications.

Mice with frequent flier miles advance the Alzheimer's cause

January 4, 2018
Alzheimer's disease wreaks emotional havoc on patients, who are robbed of their memories, their dignity, and their lives. It's financially devastating as well: care for Alzheimer's patients is predicted to top $1 trillion ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.